Scientific Program
DAY 1
September 15, 2022
Thursday | full day
08.00 am | |
| Opening Ceremony | |
| by Jens Vogel-Claussen | |
| SESSION 1: | |
Technical Advances in Functional Lung Imaging | |
| Chair: Yoshi Ohno, Jim Wild | |
| 08.10 am | |
| Past, Present and Future of Functional Lung Imaging | |
| Edwin van Beek | |
| 08.30 am | |
| Functional Lung Imaging with Proton MRI - state of the art | |
| Andreas Voskrebenzev | |
| 08.50 am | |
| 19F and 129 Xe Lung MRI – ready for clinical translation | |
| Jim Wild | |
| 09.10 am | |
| The emerging role for PET imaging in Lung disease | |
| Delphine Chen | |
| 09.30 am | |
| Deep learning: a quantum leap for Lung Imaging | |
| Joon Beom Seo | |
| 09.50 am | |
| Discussion | |
| 10.00 - 10.20 am | |
| Industry Exhibition Break | |
| SESSION 2: | |
| Lung Cancer | |
| Chairs: Hans-Ulrich Kauczor, Jin Mo Goo | |
| 10.20 am | |
| LC screening: scientific evidence and epidemiological considerations | |
| Rudolf Kaaks | |
| 10.55 am | |
| LC screening: Nodule management – Present and Future | |
| Matthijs Oudkerk | |
| 11.15 am | |
| LC Screening: What about the heart and other lung disease? | |
| Jens Vogel-Claussen | |
| 11.35 am | |
| How to build an effective screening program | |
| David Baldwin | |
| 11.55 am | |
| Therapy response Imaging – Current Status and novel developments |
| Mizuki Nishino | |
| 12.15 pm | |
| Discussion | |
| 12.25 - 12.45 pm | |
Industry Symposium I by CORELINE | |
| 12.45 - 13.30 pm | |
| Lunch break | |
| 13.30 - 15.10 pm | |
| SESSION 3: | |
| YIA (Young Investigator Award) Session | |
| Chair: Tally Altes, Edwin J.R. van Beek | |
| 15.10 - 15.30 pm | |
| Industry Exhibition Break | |
| SESSION 4: | |
| Chronic Obstructive Pulmonary Disease (COPD) | |
| Chair: David Lynch, Yasutaka Nakano | |
| 15.30 pm | |
| Critical Clinical Issues in COPD | |
| Claus Vogelmeier | |
| 15.45 pm | |
| The value of cardiopulmonary imaging in COPD cohort studies | |
| Graham Barr | |
| 16.05 pm | |
| Novel Structure-Function CT markers in COPD | |
| Eric Hoffman | |
| 16.25 pm | |
| Functional Lung MRI - emerging role in COPD | |
| Hiroto Hatabu |
| 16.45 pm | |
| Discussion | |
| 16.55 - 17.15 pm | |
| Industry Symposium II by GSK | |
| 17.15 - 18.15 pm | |
| POSTER SESSION |
DAY 2
September 16, 2022
Friday | full day
| SESSION 5: | |
| Asthma | |
| Chair: Tally Altes, Grace Parraga | |
| 09.00 am | |
| Critical Clinical Issues in Asthma | |
| Erika von Mutius | |
| 09.15 am | |
| Role of MR Functional Imaging | |
| Grace Parraga | |
| 09.35 am | |
| Role of CT Functional Imaging | |
| Yoshi Ohno | |
| 09.55 am |
| Discussion | |
| 10.05 - 10.25 am | |
| Industry Exhibition Break | |
| SESSION 6: | |
| Pulmonary Vascular Disease | |
| Chair: Marius Hoeper, David Levin | |
| 10.25 am | |
| Pulmonary Hypertension - the clinical perspective | |
| Marius Hoeper | |
| 10.40 am | |
| The role of imaging in pulmonary hypertension | |
| Andy Swift | |
| 11.00 am | |
| Pulmonary embolism: Acute, Chronic and AI | |
| Mark Schiebler | |
| 11.20 am | |
| Hyperpolarized 129Xe MRI for novel insights into Pulmonary Vascular Disease | |
| Bastiaan Driehuys | |
| 11.40 am |
| Discussion | |
| 11.50 am - 12.00 pm | |
Industry Symposium III by Siemens | |
| Photon Counting CT: The new clinical standard for lung imaging | |
| Marine Rémy-Jardin, Head of the Department of Cardiothoracic Imaging, University Centre of Lille, France | |
| 12.00 - 13.00 pm | |
| Lunch break | |
| SESSION 7: | |
| Infection and Inflammation | |
| Chairs: Tobias Welte, Mark Schiebler | |
| 13.00 pm | |
| Lessons learned from the COVID-19 pandemic | |
| Tobias Welte | |
| 13.15 pm | |
| COVID-19 - the role of imaging and future perspectives | |
| Hans-Ulrich Kauczor | |
| 13.35 pm | |
| COVID-19 – Novel insights from Microstructure Imaging |
| Danny Jonigk | |
| 13.55 pm | |
| Discussion | |
| 14.05 - 14.25 pm | |
| Industry Exhibition Break | |
| SESSION 8: | |
| Interstitial Lung Disease (ILD) | |
| Chairs: Juergen Biederer, Hiroto Hatabu | |
| 14.25 pm | |
| ILDs - What the radiologist needs to know | |
| David Lynch | |
| 14.40 pm | |
| Critical Clinical Issues in IPF | |
| Antje Prasse | |
| 15.00 pm | |
| Novel CT biomarker for monitoring ILD | |
| Jin Mo Goo | |
| 15.20 pm | |
| The emerging role of functional lung MRI in ILD | |
| Christopher Johns | |
| 15.40 pm | |
| Discussion | |
| 16.00 - 16.15 pm | |
| Industry Symposium IV by Bayer | |
| 19.00 pm | |
| EVENING EVENT | |
| Dinner at Hannover New Town Hall & Award Ceremony |
DAY 3
September 17, 2022
Saturday | half day
| SESSION 9: |
| Lung Microstructure |
| Chairs: Eric Hoffman, Jens Vogel-Claussen |
| 09.00 am |
| Multiscale imaging of the human lung |
| Willi Wagner |
| 09.20 am |
| Microstructure Imaging of the lung with hyperpolarized Gas MRI |
| Agilo Kern |
| 09.40 am |
| New Horizons: Dark field imaging of the lungs |
| Franz Pfeiffer |
| 10.00 am |
HP gas imaging in COVID-19 |
| Mitchell Albert |
| 10.20 am |
| Discussion |
| 10.30 - 10.45 am |
| Coffee break |
| SESSION 10: |
| Pediatric Lung Disease |
| Chairs: Giles Santyr, Jason Woods |
| 10.45 am |
| The emerging clinical role of functional lung MRI in newborns and infants |
| Jason Woods |
| 11.00 am |
| The growing clinical role of functional lung MRI in CF |
| Mark Wielpütz |
| 11.25 am |
| Opportunities of hyperpolarized 129Xe gas MRI in children with lung disease |
Giles Santyr |
| 11.45 am |
| Discussion |
| 12.00 am |
| END |